Benfotiamine 150 mg By Klaire Labs Overview & Drug Interactions
Check For Interactions With Benfotiamine 150 mg
Supplement: Benfotiamine 150 mg by Klaire Labs
Benfotiamine 150 mg Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Thiamine
| Ingredient Group | Thiamin |
|---|---|
| Category | vitamin |
-
Benfotiamine
Description:Benfotiamine is a synthetic derivative of thiamine (vitamin B1) with enhanced bioavailability. It is often used as a dietary supplement to support overall health and address conditions related to thiamine deficiency. Unlike thiamine, benfotiamine is lipid-soluble, allowing it to penetrate cell membranes more effectively. This enhanced absorption is believed to contribute to its potential therapeutic benefits in managing diabetic complications, neuropathy, and oxidative stress.
See More Information Regarding Benfotiamine
Ingredient Group Benfotiamine Category vitamin Forms- S-Benzoylthiamine-O-Monophosphate
Drugs that interact with Benfotiamine 150 mg by Klaire Labs
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
There were no interactions found with Benfotiamine 150 mg. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Capsule(s)
|
| Maximum serving Sizes: |
1 Capsule(s)
|
| Servings per container | 60 |
| UPC/BARCODE | 828054001275 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Thiamine |
150 mg
|
Thiamin |
12500%
|
| Benfotiamine |
150 mg
|
Benfotiamine |
|
| Other Ingredients: |
Vegetarian Capsule
Forms
Microcrystalline Cellulose
L-Leucine
Silicon Dioxide
|
|---|
Label Statments:
| FDA Statement of Identity |
- Vitamin B1 Supplement
|
|---|---|
| Brand IP Statement(s) |
- SFI
|
| Precautions |
- Caution: If you are pregnant, nursing, have a medical condition, or taking prescription drugs, consult your physician before using this product.
- Keep out of reach of children.
- Do not use if shrinkwrap is broken or missing.
|
| Formulation |
- Free of the following common allergens: Milk/casein, eggs, fish, shellfish, tree nuts, peanuts, wheat, gluten, soybeans, corn, and yeast. Contains no artificial colors, flavors, or preservatives.
- Produced under a strict quality management system in compliance with Good Manufacturing Practices (GMPs) and third-party quality certifications.
|
| Formula |
- Benfotiamine is a lipid-soluble derivative of vitamin B1 (thiamin) with high bioavailability. It is better absorbed than water-soluble forms of thiamin and has an estimated bioavailability of up to 3.6 times as high as compared to thiamin hydrochloride, making benfotiamine especially useful for people with absorption difficulties.
|
| Storage |
- Store in a cool, dry place (59 degrees F - 85 degrees F) away from direct light.
|
Brand Information
See all products by this brand
| Manufactured by | |
|---|---|
| Name | SFI USA |
| City | Reno |
| State | NV |
| ZipCode | 89521 |
| Web Address | Klaire.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.